124I-PET/CT based tumor dosimetry for 131I therapy of metastatic differentiated thyroid cancer (DTC) - a comparison of recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal patient preparation methods - 2015


MedStar Washington Hospital Center


Medicine/Nuclear Medicine